Clinical Trials in New York

Showing 5481-5500 of 22,668 trials

A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma

NCT04212013

The purpose of this study is to see if the combination of rituximab and ibrutinib can help people with marginal zone lymphoma who have not received treatment in the past. The study will also compare the combination of rituximab and ibrutinib with the combination of rituximab and placebo to see which combination works better.

Marginal Zone Lymphoma

Memorial Sloan Kettering Cancer Center23 participantsStarted Dec 2019

Washington D.C., District of Columbia, United States • Tampa, Florida, United States • Rochester, Minnesota, United States +7 more locations

COMPLETEDPhase 2< 1 mile

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

NCT04924101

The purpose of this study is to evaluate the use of investigational agents (MK-4830, boserolimab (MK-5890) and lenvatinib (MK-7902)) in combination with pembrolizumab (MK-3475) and etoposide/platinum chemotherapy for the first-line treatment of participants with extensive-stage small cell Lung Cancer (ES-SCLC). No formal hypothesis testing will be performed for this study.

Small Cell Lung Cancer

Merck Sharp & Dohme LLC126 participantsStarted Jul 2021

Gilbert, Arizona, United States • Aurora, Colorado, United States • Atlanta, Georgia, United States +46 more locations

A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

Find Trials by Condition in New York

Secur-Fit Advanced Outcomes Study

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

Preventing Early-Onset Colorectal Cancer in the VA

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Bite Force Measurements

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

A Multi-Center Clinical Trial in Individuals With Spinal Cord Injury

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

Motivational Refinements for Facilitating Reinforcement Schedule Thinning

Computer Based Treatment for Cognitive Behavioral Therapy and Cooperative Pain Education and Self-Management

Study Evaluating the Safety and Efficacy of AR-15512

Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)